Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.
This clinical-stage biotech develops therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition.
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر S والمشاعر والاتجاه
This clinical-stage biotech develops therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition.
The rollout provides access to tokenized US stocks, ETFs and commodities through Ondo GM tokens for non-US users on Ethereum, …
Investors are cheering Palantir’s bullish 2026 revenue guidance as the company’s AI strategy continues to be a bright spot in …
CNBC’s Jim Cramer took to social media on Monday to explain a counterintuitive slump in the stock market, attributing the …
PayPal just saw a major slowdown on a metric that’s closely watched by investors. Soon HP veteran Enrique Lores will …
The Morning Bull - US Market Morning Update Tuesday, Feb, 3 2026 US stock futures are slightly higher this morning, …
تحليل متعدد المزودين بالذكاء الاصطناعي